Skip to content
Wednesday, October 28, 2026 · Today’s edition, 6:30 a.m. ETWed, Oct 28 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in

Who holds AMLXAMYLYX PHARMACEUTICALS

9 funds on our shelf carry AMYLYX PHARMACEUTICALS — heaviest hand: XPH at 2.04% of its book.

FundWeightFund assetsShares held
XPHState Street SPDR S&P Pharmaceuticals ETFINDEX2.04%$487M485,721
IHEiShares U.S. Pharmaceuticals ETFINDEX0.61%$1.6B346,682
DWASInvesco Dorsey Wright SmallCap Momentum ETFINDEX0.34%$411M48,343
IBBQInvesco Nasdaq Biotechnology ETFINDEX0.23%$112M9,633
VTWGVanguard Russell 2000 Growth ETFINDEX0.20%$1B112,877
IBBiShares Biotechnology ETFINDEX0.20%$10.6B816,176
IWOiShares Russell 2000 Growth ETFINDEX0.19%$14.4B967,053
VFMOVanguard U.S. Momentum Factor ETFINDEX0.17%$646M118,212
VHTVanguard Health Care Index FundINDEX0.04%$19B267,964

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.